• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Indication for splenectomy combined with total gastrectomy for gastric cancer: analysis of data on 249 gastric cancer patients.

作者信息

Takahashi M, Fujimoto S, Kobayashi K, Takai M, Endoh F, Ohkubo H

机构信息

Division of Surgery, Social Insurance Funabashi Central Hospital, Japan.

出版信息

Hepatogastroenterology. 1995 Jul;42(3):230-3.

PMID:7590570
Abstract

This study analyzed intraoperative indication for splenectomy at the time of total gastrectomy, based on 249 gastric cancer patients. Data on these patients were studied with special reference to the relationship between intraoperative gross findings such as serosal invasion, tumor size, histologic patterns and nodal metastasis to the splenic hilus. Fifty-three of the 249 patients (21.3%) had a positive metastasis. The incidence of nodal metastasis to the splenic hilus was high in patients with a primary lesion in the entire stomach (26/72: 36.1%). In case of no serosal invasion of the primary lesion, there was no nodal involvement to the splenic hilus (0/42). The low incidence of nodal metastasis occurred in case of a tumor size of less than 40 mm in the largest diameter (1/60: 1.7%) and with histological findings of signet ring cell carcinoma (1/19: 5.3%). Although site and size of the primary tumor, depth of tumor penetration, and histologic findings are interdependent variables, these factors indicate probable nodal involvement to the splenic hilus and unnecessary splenectomy can be avoided.

摘要

相似文献

1
Indication for splenectomy combined with total gastrectomy for gastric cancer: analysis of data on 249 gastric cancer patients.
Hepatogastroenterology. 1995 Jul;42(3):230-3.
2
Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer.近端胃癌脾门淋巴结转移的频率及脾切除术的效果
Anticancer Res. 2009 Aug;29(8):3347-51.
3
Indication of splenectomy for gastric carcinoma involving the proximal part of the stomach.
Hepatogastroenterology. 2001 Mar-Apr;48(38):603-5.
4
Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.进展期胃癌患者行全胃切除联合脾切除/胰脾切除术的术后发病率/死亡率及生存率。
Hepatogastroenterology. 2004 Jan-Feb;51(55):298-302.
5
[Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].[胃癌根治性胃切除术联合脾切除术的长期疗效分析]
Zhonghua Wai Ke Za Zhi. 2005 Sep 1;43(17):1114-7.
6
Indications for a pylorus-preserving gastrectomy for gastric cancer with proper muscle invasion.伴有适当肌层浸润的胃癌行保留幽门胃切除术的适应证。
Arch Surg. 2003 Nov;138(11):1235-9. doi: 10.1001/archsurg.138.11.1235.
7
Lymph node metastasis at the splenic hilum in proximal gastric cancer.近端胃癌脾门处的淋巴结转移
Am Surg. 2004 Jul;70(7):645-8.
8
Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.胃近端癌脾门淋巴结转移的临床意义
Ann Surg Oncol. 2009 May;16(5):1304-9. doi: 10.1245/s10434-009-0389-5. Epub 2009 Feb 25.
9
Effect of simultaneous splenectomy on the survival of patients undergoing curative gastrectomy for proximal gastric carcinoma.同期脾切除术对近端胃癌根治性胃切除术患者生存的影响。
Surg Today. 2003;33(4):254-8. doi: 10.1007/s005950300057.
10
Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus.近端胃癌的脾切除术:脾门淋巴结转移的频率
J Surg Oncol. 2001 Feb;76(2):89-92. doi: 10.1002/1096-9098(200102)76:2<89::aid-jso1016>3.0.co;2-i.

引用本文的文献

1
Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Surg Today. 1999;29(6):504-10. doi: 10.1007/BF02482344.